首页> 外文期刊>The journal of alternative and complementary medicine: research on paradigm, practice, and policy >Prospective Safety Evaluation of a Cardiovascular Health Dietary Supplement in Adults with Prehypertension and Stage I Hypertension
【24h】

Prospective Safety Evaluation of a Cardiovascular Health Dietary Supplement in Adults with Prehypertension and Stage I Hypertension

机译:患有毛发生儿急性血管和阶段高血压的成人心血管健康膳食的预期安全性评价

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective: To prospectively examine the long-term safety of a cardiovascular health dietary supplement by assessing a comprehensive set of safety measures. Design: Single-arm, open-label study. Location: National University of Natural Medicine, Portland, OR. Subjects: Thirty adults with screening blood pressure readings consistent with prehypertension or stage I hypertension. Intervention: One caplet per day of a dietary supplement for 6 months. The investigated herbal-mineral supplement contains several ingredients, most notably Rauwolfia serpentina. Outcome measures: Primary measures included b-type natriuretic peptide (NT-proBNP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), estimated glomerular filtration rate (eGFR), electrolytes, and the Patient Health Questionnaire (PHQ-9). Exploratory measures included physical vital signs, cholesterol levels, high-sensitivity cardiac troponin-I, cystatin C, endothelin, interleukin (IL)-6, IL-17a, tumor necrosis factor-, high-sensitivity C-reactive protein, blood counts, and the Patient Reported Outcome Measure Information System (PROMIS) Sleep Disturbance Short Form 8b. Results: NT-proBNP, AST, ALT, eGFR, sodium, calcium, magnesium, PHQ-9 score, and the majority of exploratory measures did not change. However, serum potassium increased (p<0.05), systolic blood pressure decreased (p<0.0001), and diastolic blood pressure decreased (p<0.0001). There were no serious adverse events, but 30% of participants withdrew citing potential side effects, most commonly nasal congestion or fatigue; most participants who reported nasal congestion also reported concomitant seasonal allergies. Adherence to the supplement was 90.9%. Conclusions: The findings of this study suggest that the investigated dietary supplement is safe for long-term use in adults with prehypertension and stage I hypertension. Additional results of this study, particularly the increase in serum potassium and decreases in systolic and diastolic blood pressure, are promising and suggest that future research on this dietary supplement, or its ingredients, should further explore effects on blood pressure and biologic mechanisms of action, which may involve potassium-sparing and diuretic effects.
机译:目的:通过评估一套全面的安全措施,预期探讨心血管健康膳食补充剂的长期安全性。设计:单臂,开放标签学习。地点:国立自然医学大学,波特兰,或。受试者:30例成年人,筛查血压读数与毛细管急性或I阶段的高血压。干预:每天膳食补充剂的一个伴侣6个月。调查的草药矿物质补充剂含有几种成分,最值得注意的是Rauwolfia Serpentina。结果措施:初级措施包括B型利钠肽(NT-PROPNP),天冬氨酸氨基转移酶(AST),丙氨酸氨基转移酶(ALT),估计的肾小球过滤速率(EGFR),电解质和患者健康调查问卷(PHQ-9)。探索性措施包括物理生命体征,胆固醇水平,高灵敏度心肌肌钙蛋白-i,胱抑素C,内皮素,白细胞介素(IL)-6,IL-17a,肿瘤坏死因子,高敏感性C-反应蛋白,血液计数,患者报告了结果测量信息系统(PROMIS)睡眠障碍短表8B。结果:NT-probnp,AST,ALT,EGFR,钠,钙,镁,PHQ-9分数,以及大部分探索措施没有变化。然而,血清钾增加(P <0.05),收缩压降低(P <0.0001),舒张压降低(P <0.0001)。没有严重的不良事件,但30%的参与者撤回了潜在的副作用,最常见的鼻塞或疲劳;报告鼻塞的大多数参与者也报告了伴随的季节性过敏。依从补充剂为90.9%。结论:本研究的结果表明,调查的膳食补充剂对成年人的长期用途是安全的,毛细管疗法和阶段的I高血压是安全的。本研究的其他结果,特别是血清钾的增加和收缩性和舒张血压降低,并提出了对这种膳食补充剂或其成分的未来研究应该进一步探索对血压和生物学机制的影响,这可能涉及钾盐和利尿效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号